Why do legacy medical devices create a different risk model from ordinary IT assets?

Legacy medical devices can affect patient safety directly, remain in use long after vendor support ends, and may be difficult or impossible to patch. That means risk decisions must account for continuity of care, not just confidentiality and availability in the usual IT sense.

Why This Matters for Security Teams

Legacy medical devices do not behave like ordinary endpoints. They may run unsupported operating systems, use proprietary protocols, or sit in regulated clinical workflows where downtime is not just an IT inconvenience. A device issue can trigger patient harm, delayed treatment, or loss of clinical trust, so the risk model has to include safety, service continuity, and evidence of control effectiveness. That is why frameworks such as the NIST Cybersecurity Framework 2.0 are useful as a baseline, but not sufficient on their own unless adapted to the clinical context.

Security teams often get this wrong by treating these assets as simply “hard to patch” systems and then applying standard IT remediation timelines. In healthcare, that can create an unacceptable gap between technical risk acceptance and clinical accountability. Governance has to include asset owners, biomedical engineering, clinical leadership, and security together, because the decision is rarely just whether a device is vulnerable. It is whether compensating controls are strong enough to keep care safe while the device remains in service. In practice, many security teams encounter the real risk only after a device is already embedded in care delivery and replacement is no longer a quick option.

How It Works in Practice

The practical difference starts with asset classification. A legacy infusion pump, monitor, imaging system, or lab instrument should be assessed for patient safety impact, clinical dependency, patchability, and exposure to adjacent systems. That means the question is not only “can it be exploited?” but also “what happens if it fails, misbehaves, or is taken offline for maintenance?” Current guidance suggests using risk-based segmentation, compensating controls, and documented exceptions rather than assuming all devices can follow the same hardening standard.

In mature environments, teams usually combine several control layers:

• Network isolation and tightly scoped communication paths to reduce lateral movement.
• Continuous inventory so unsupported devices are known, not discovered during an incident.
• Compensating controls such as allowlisting, monitoring, and restricted admin access when patching is impossible.
• Change control that includes clinical scheduling, not just maintenance windows.
• Incident response playbooks that define when to contain, when to preserve service, and who can authorize downtime.

NIST SP 800-53 Rev 5 Security and Privacy Controls is helpful here because it provides control families for access control, system integrity, audit logging, and contingency planning. Those controls need to be translated into clinical operations, where a device cannot always be rebuilt, rebooted, or isolated without operational consequences. Security monitoring also has to be tuned carefully, because noisy alerting on fragile devices can create alert fatigue or discourage proper use. These controls tend to break down when a hospital lacks authoritative inventory and cannot distinguish life-critical devices from low-impact peripherals because the compensating controls then become inconsistent and difficult to defend.

Common Variations and Edge Cases

Tighter segmentation often increases operational overhead, requiring organisations to balance attack reduction against clinical availability. That tradeoff becomes sharper in environments with mixed generations of devices, shared vendor support models, or remote service contracts that require inbound access. Best practice is evolving on how much compensating control is enough for end-of-life medical equipment, and there is no universal standard for this yet. The right answer depends on risk tolerance, clinical criticality, and whether replacement is feasible within the device’s remaining life.

Edge cases also matter. Some devices are technically legacy but remain well-contained because they communicate through a dedicated gateway or managed clinical network. Others appear low risk because they are not internet-facing, yet they connect to imaging, records, or pharmacy systems and can be used as a pivot point. In those cases, the risk is not just the device itself but the trust placed in its surrounding ecosystem. Where the device supports remote vendor servicing, identity and access governance become part of the answer: named accounts, session logging, and time-bound access are preferable to shared credentials, even when full modern PAM is not available. The core principle is to preserve care delivery while steadily reducing exposure, not to force a generic enterprise security pattern onto equipment that cannot support it.

Related resources from NHI Mgmt Group

• Why do deepfake attacks create a different identity risk than ordinary phishing?
• Why do non-human identities create more attack-surface risk than ordinary assets?
• Why do model fine-tuning permissions create a bigger risk than ordinary cloud permissions?
• Why do connected medical devices create identity security risk for hospitals?